tirzepatide adolescent obesity trial A 3-year study of in participants with and prediabetes showed substantial and sustained weight reduction and decreased risk of progression to diabetes with tirzepatide, as compared with placebo. Full SURMOUNT-1 tirzepatide adolescent obesity trial Efficacy
Pay in 4 interest-free payments of $6.97 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 31 - Nov 5
01774-X/asset/3608bfb3-6329-4132-95b7-cc3434437493/main.assets/gr2_lrg.jpg)
01774-X/asset/53e5d1a3-0894-4bca-91bb-d3f2fb7acb4f/main.assets/gr3.jpg)




















